National Association of Boards of Pharmacy

JUNE 6, 2022

Their availability is at least in part due to Drug Enforcement Administration’s (DEA’s) March 2020 decision to loosen remote prescribing restrictions for Schedule III through Schedule V controlled substances (CS) for the duration of the public health emergency.

Online Pharmacies 52

Online Pharmacies Controlled Substances Prescription Filling 52

FDA Law Blog: Biosimilars

FEBRUARY 27, 2024

Our last two PTE-related posts concerned the issues of: (1) multiple PTEs—a topic we blogged on in 2020 , but that we have been following since the very early days of the FDA Law Blog in 2008 and 2009 (see our previous posts here , here , and here )—and (2) the Improving Regulatory Transparency for New Medical Therapies Act (“IRTNMTA”)—a topic we blogged (..)

Controlled Substances 59

Controlled Substances Hospitals 59

STAT

JANUARY 15, 2025

The Drug Enforcement Administration on Wednesday issued an announcement 16 years in the making: it will create a special registration process for prescribers wishing to provide controlled substances, like opioids or stimulants used to treat ADHD, via telemedicine. 

Controlled Substances 326

Controlled Substances 326

FDA Law Blog: Biosimilars

NOVEMBER 21, 2024

temporary exceptions from some of the requirements of the Ryan Haight Act of 2008) are extended for an additional year, until December 31, 2025. use of buprenorphine) for opioid use disorder, and for Schedule III-V non-narcotic controlled substances unless the patient receives an in-person examination.

Controlled Substances 52

Controlled Substances 52